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The Proteomics of N-terminal Methionine
Cleavage*□S
Fre´de´ric Frottin‡§, Aude Martinez‡§, Philippe Peynot‡, Sanghamitra Mitra¶,
Richard C. Holz¶, Carmela Giglione‡, and Thierry Meinnel‡**
Methionine aminopeptidase (MAP) is a ubiquitous, essen-
tial enzyme involved in protein N-terminal methionine ex-
cision. According to the generally accepted cleavage
rules for MAP, this enzyme cleaves all proteins with small
side chains on the residue in the second position (P1), but
many exceptions are known. The substrate specificity of
Escherichia coli MAP1 was studied in vitro with a large
(>120) coherent array of peptides mimicking the natural
substrates and kinetically analyzed in detail. Peptides
with Val or Thr at P1 were much less efficiently cleaved
than those with Ala, Cys, Gly, Pro, or Ser in this position.
Certain residues at P2, P3, and P4 strongly slowed the
reaction, and some proteins with Val and Thr at P1 could
not undergo Met cleavage. These in vitro data were fully
consistent with data for 862 E. coli proteins with known
N-terminal sequences in vivo. The specificity sites were
found to be identical to those for the other type of MAPs,
MAP2s, and a dedicated prediction tool for Met cleavage
is now available. Taking into account the rules of MAP
cleavage and leader peptide removal, the N termini of all
proteins were predicted from the annotated genome and
compared with data obtained in vivo. This analysis
showed that proteins displaying N-Met cleavage are over-
represented in vivo. We conclude that protein secretion
involving leader peptide cleavage is more frequent than
generally thought. Molecular & Cellular Proteomics 5:
2336–2349, 2006.
Protein N-terminal methionine excision (NME)1 is an essen-
tial cotranslational process that occurs in the cytoplasm of all
organisms and in the two organelles (i.e. mitochondria and
plastids) displaying protein synthesis (for reviews, see Refs. 1
and 2). NME involves two types of methionine aminopepti-
dase (MAP), MAP1 (type-I) and MAP2 (type-II), which have
similar three-dimensional structures despite having only low
levels of sequence identity (for a review, see Ref. 3). Higher
eukaryotes have at least one MAP1 (MAP1A, also known as
MetAP1b; Ref. 4) and one MAP2 in the cytoplasm and one
MAP1 (MAP1D) in the organelles. Archaea, such as Pyrococ-
cus furiosus, have one MAP2, and eubacteria, such as Esch-
erichia coli, have only MAP1. In eubacteria and the organelles,
a peptide deformylase systematically removes the N-formyl
group, leading to the activation of MAP cleavage (5–7). Bac-
terial MAP1 cannot cleave N-blocked polypeptides (6).
The role of NME remains poorly understood (2), but this
process is recognized to be the major source of N-terminal
amino acid diversity. It is thought that up to 80% of the
proteins of any given proteome undergo this modification
(8–10). Early biochemical and genetic studies indicated that
this activity was very specific for peptides with an N-terminal
Met residue (P1 position according to Schechter’s nomencla-
ture, Ref. 11), and the penultimate position (P1) was identified
as the major determinant for cleavage (for reviews, see Refs.
12 and 13). The rule of thumb is that cleavage occurs if the
side chain is small enough as is the case for Ala, Cys, Pro, Ser,
Thr, and Val. According to this rule, cleavage is not possible
for larger side chains. This stochastic rule, which emerged
from early bioinformatics analysis based on compilation of the
few protein sequences available at the time (14), was con-
firmed by biochemical analysis of MAP activity in vitro with
about a dozen model tri- and tetrapeptides (6, 15, 16). Edman
degradation sequencing of two reporter proteins in E. coliwas
used to further the analysis (17, 18). The authors of these
studies suggested that the process was statistical rather than
stochastic and that cleavage efficiency was correlated with
side-chain length or gyration radius as defined by Levitt (19) at
P1 (20). This is fully confirmed by the structural analysis of
many MAPs (3, 4). Cleavage probability was found to be
highest for Gly (97%) followed by Ala, Thr (90%), Pro, Ser, and
Val (84%). Cleavage was less probable for the substrates Cys
(71%), Ile (18%), Asp, Leu, and Asn (16%). The underlying
idea is that the S1 binding pocket, into which the P1 side
chain must fit, is small and tolerates smaller side chains with
Gly being the optimal residue. However, these two analyses
were based on only two reporter proteins, although the com-
parison was straightforward as the protein sequences differed
only at position P1. These findings form the basis of our
current understanding of the process (for a review, see Ref. 1;
see also Fig. 1 in Ref. 21), which is used for bioinformatics
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analysis of the process in genomes (see Scheme 1 and Fig. 4
in Ref. 22). More recent proteomics analysis in E. coli (23, 24)
has generated a comprehensive overview, and the N terminus
has now been clearly determined for the products of a total of
862 open reading frames (of the 4071 proteins in the E. coli
proteome). However, the conclusions of this analysis (23)
conflicted with the deduced rules of NME. Unlike proteins with
Ala and Ser at P1, the authors concluded that those with Gly,
Pro, and Thr in this position displayed fastidious, “variable
cleavage.” Finally proteins with Val at P1 were found to resist
NME.
It is therefore difficult to predict the rules of N-terminal
cleavage reliably based on a compilation of all these data. For
example, it is unclear whether proteins with Gly, Pro, Thr, Val,
Cys, Ile, Asp, Asn, or Leu at P1 are cleaved and, if so,
whether some of the rules for MAP cleavage have yet to be
determined or whether other competing mechanisms, such as
protein exportation, secretion, or insolubility due to mem-
brane localization, may have biased analysis in vivo. This
ambiguity makes reliable proteome annotations difficult for
27% of the proteins in the bacterial proteome and renders the
production of recombinant proteins of therapeutic interest
risky given the high antigenicity of the N terminus if incorrectly
processed (25). This problem was initially encountered in the
production of human hemoglobin (26). Closer examination of
published biochemical analyses (6, 15, 16, 27) showed that
these analyses were not really systematic as they compared
peptides of different lengths with different residues in posi-
tions 3 (P2) and 4 (P3). These differences may have greatly
influenced data interpretation. In addition, by analogy with the
cleavage rules of similar peptidases with extended recogni-
tion regions around the cleavage site, it is unclear whether
MAP enzymes have a P2 or a P3 recognition site (S2 and
S3) and whether these two sites influence substrate speci-
ficity in vivo. Furthermore we noted that, in analyses in vitro,
data were systematically compared at fixed peptide concen-
trations (usually 4 or 20 mM), although Km values are known to
range from 1 to 5 mM, and the steady-state concentration of
the nascent peptide is of the order of 0.1 mM (28). Thus,
kcat/Km measurements (i.e. catalytic efficiency) were required
for the modeling of MAP activity from in vitro studies, facili-
tating the comparison of coherent peptide series essential for
the drawing of definitive conclusions.
The aim of this study was to reconcile the data from in vivo
and in vitro analysis using combined biochemical and bioin-
formatics analysis to draw a definitive and coherent picture of
NME and its cleavage rules in vivo. We first used E. coli as a
model system, making use of the large body of in vivo se-
quence determination data for the direct comparison of in
vitro and in vivo data. We found that proteins with Thr and Val
at P1 were poor substrates of MAP1 and MAP2, frequently
resisting NME cleavage, and that the P2 and P3 positions
had a strong effect on specificity for both MAP types. These
elements would be expected to have different effects on
intrinsic protein processing in the natural proteome or the
overproduction of foreign, recombinant proteins in bacteria.
EXPERIMENTAL PROCEDURES
Chemicals and Peptides—All chemicals were purchased from
Sigma. Most peptides were synthesized as custom products at Gen-
script Corp. (Piscataway, NJ). Others were purchased from Bachem
(Well-am-Rhein, Germany) or Sigma. All peptides were 95% pure
and were dissolved in water at a final concentration of 50–150 mM.
Heating at 50 °C was required to achieve dissolution in a few cases.
Four peptides (MGF, MFG, MWG, MGW, and MPG) had to be dis-
solved in water plus dimethyl sulfoxide (5–10% final concentration) at
a concentration of 3–10 mM. Each addition of 1% dimethyl sulfoxide
to the MAP-coupled assay was found to decrease MAP activity by
only 10%.
Methionine Aminopeptidase Purification—Native E. colimethionine
aminopeptidase (EcMAP1) was overproduced from plasmid pXL1071
(29). JM83 cells expressing the plasmid were grown at 37 °C for 8–12
h in 2 TY medium (16 g/liter Bacto-tryptone, 10 g/liter Bacto-yeast
extract, 5 g/liter NaCl and adjusted to pH 7.0 with NaOH) supple-
mented with 50 g/ml ampicillin to an A600 of  0.9. Cells were
induced with 0.3 mM isopropyl 1-thio--D-galactopyranoside and in-
cubated for a further 12 h with shaking. The cells were harvested by
centrifugation and resuspended in 10–20 ml of buffer A consisting of
50 mM KHPO4 (pH 7.5) and 0.2 mM CoCl2. The samples were soni-
cated, and cell debris were removed by centrifugation. The superna-
tant was subjected to 0–80% ammonium sulfate precipitation and
centrifuged for 30 min at 4 °C. The pellet was resuspended in 5 ml of
buffer A, applied to a Superose-6 column (1.6  60 cm; GE Health-
care) and eluted at a flow rate of 0.5 ml/min in buffer A. The pool with
MAP activity (30 ml) was loaded on a Q-Sepharose (1.6  10 cm; GE
Healthcare) anion-exchange column equilibrated in buffer A, and the
sample was eluted with a 0.2 M/h linear NaCl gradient (2.5 ml/min).
The proteins recovered were homogeneous and were stored at
30 °C in buffer A plus 55% glycerol. P. furiosusMAP2 (PfMAP2) was
purified as described elsewhere (30).
MAP Activity Measurements—MAP activity was assayed at 30 °C
by continuously monitoring the absorbance of oxidized o-dianisidine
at 440 nm, coupling MAP activity to both L-amino-acid oxidase and
peroxidase activities, according to Scheme 1 (where Aaa is any
-amino acid).
methionine aminopeptidase (MAP)
L-Aaa-peptide  H2O3 L-Aaa  peptide (1)
L-amino-acid oxidase
L-Aaa  H2O  O23 2-oxo-Aaa  NH3  H2O2 (2)
peroxidase
H2O2  o-dianisidine3 H2O  o-dianisidine[ox] (3)
SCHEME 1
The conditions of this assay were set according to published
observations (16, 31–33). The standard assay was performed in a final
volume of 100 l in plastic cuvettes with a 1-cm optical path (UV-
ettes; Eppendorf). Changes in absorbance over time were followed
using an Ultrospec-4000 spectrophotometer (GE Healthcare)
equipped with a thermostat and a six-position Peltier heated cell
changer. The reaction mixtures (95 l) contained (final concentrations
in 100 l) 45 mM Hepes, pH 7.4, 0.2 mM CoCl2 (Sigma; catalog
number C8661) unless otherwise stated (Fig. 1A), 0.1 mg/ml o-diani-
sidine (Sigma; catalog number D9154, solution prepared from one
tablet every other day and stored at 4 °C in the dark), 3 units of
horseradish peroxidase (2000 units/ml, Sigma; catalog number
P8415, stored for months at 20 °C), 0.5 units of L-amino-acid oxi-
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dase (63 units/ml, Sigma; catalog number A9378, stored for months
at 4 °C in the dark), and 0.01–20 mM peptide (see above). This
premixture was incubated for 4–15 min in the spectrophotometer at
30 °C until the base line at 440 nm was stable. At this point, the
spectrophotometer was set to zero. The reaction was started by
adding 5 l of purified 0.1–20 M (final concentration) MAP in 50 mM
Hepes, pH 7.4, 0.2 mM CoCl2, and 150 mM NaCl, and the reaction was
followed for 2–15 min. The initial velocity could generally be calcu-
lated after the first 2 min for MAP1 and the first 5 min for MAP2. This
assay can measure six velocities of 0.001–0.5 A440/min in parallel;
this is generally sufficient to determine the catalytic constants. Above
0.5 A440/min, MAP must be diluted. The measured velocities were
transformed into s1 by dividing the values by the enzyme concen-
tration used, the molar extinction coefficient of oxidized o-dianisidine
(10,580 M1cm1 as determined experimentally by incubating L-Met
in the reaction mixture and allowing the reaction to continue to
completion), and the length of the optical path (1 cm). Amino-acid
oxidase has a broad enough substrate specificity for the efficient
oxidation of many amino acids (31). Cysteine-containing peptides
were systematically avoided as they are not compatible with the
assay. This incompatibility is probably due to reduction, by the thiol
group of Cys, of the H2O2 produced by amino-acid oxidase and used
as the substrate of peroxidase, resulting in assay inhibition. We con-
firmed that the coupled assay was indeed inhibited by the Cys-Gly
dipeptide. In a few cases, at concentrations higher than the Km value,
we noted that establishment of the stationary phase was delayed,
although the associated reason was unclear. This problem was easily
avoided provided kinetics was followed for a longer time.
Interpretation of Kinetic Data—The kinetic parameters kcat and Km
were obtained using Enzyme Kinetics module 1.1 of Sigma plot
(version 8.0) by non-linear Michaelis-Menten equation fitting. The
confidence limits given are those associated with the data set. The
kinetic parameter kcat/Km was derived from iterative non-linear least
square fits of the Michaelis-Menten equation using the experimental
data (34). Confidence limits for the fitted kcat/Km values were deter-
mined by 100 Monte Carlo iterations using the experimental standard
deviations on individual measurements. We obtained similar data with
the two peptides of the same sequence obtained from (i) the same
supplier and (ii) two different suppliers.
Sequence Databases and Protein Pattern Syntax—The 4071 ORF
sequences of E. coli were retrieved from the EcoGene website
(ecogene.org/VerifiedInfo.php?downloadtrue). The compiled N-
terminal protein sequence data were retrieved from bmb.med.
miami.edu/EcoGene/EcoWeb/CeSSPages/VerifiedProts.htm (see
also Ref. 35). The data were ordered and classified by categories for
statistical analysis. The complete proteomes of Bacillus subtilis and
P. furiosus were retrieved at www.ebi.ac.uk/integr8/FtpSearch.do;
jsessionid98818969299187E6D1B9222E3B694316?orgProteomeId
6 and www.ebi.ac.uk/integr8/OrganismHomeAction.do?orgPro-
teomeID77, respectively.
We searched for protein patterns (36) at www.infobiogen.fr/
services/analyseq/cgi-bin/patternp_in.pl. The pattern syntax used in
this text was: “M” constrains the pattern to the N-terminal residue
(i.e. an initiator Met), “(^XY)” means that residues X and Y (or a subset
list) are excluded, and “(Y/Z)” means that residue Y or Z (or a subset
list) is included. X, Y, or Z correspond to any normal amino acid.
RESULTS
Validation of the Experimental in Vitro Model, E. coli Methi-
onine Aminopeptidase (EcMAP1)—A high throughput, sub-
strate-independent assay was required to investigate Ec-
MAP1 substrate specificity. Most of the available assays were
not suitable (37–39). The only available test that appeared fully
independent of the peptide sequence had only been used in a
discontinuous manner. This assay involved coupling with two
other activities, those of amino-acid oxidase and peroxidase
(16, 31–33). We set up this assay for use in continuous con-
ditions. This continuous version of the assay proved ex-
tremely rapid, reliable, and cheap, and all the peptides used
were soluble enough for kinetic measurements. That Cys-
containing peptides inhibited the assay as a result of the
reducing effect of the thiol group of Cys made it necessary to
ensure that none of the peptides tested included a Cys. Other
MAP activity assays are also subject to interference from
Cys-containing peptides (40). However, this problem is not
particularly important as Cys is the rarest amino acid at the N
termini of proteins. For example, only six (0.17%) of the 4071
ORFs of E. coli are predicted to have a Cys as the second
residue, 14 (0.34%) are predicted to have a Cys as the third
residue, and 26 are predicted to have a Cys as the fourth
residue (0.64%). Thus, our study covers 99% of the proteins
of E. coli.
We first assessed the relevance of our assay with our
purified EcMAP1. We evaluated the impact of the nature of
the cocatalytic metal cation (see references compiled in Ref.
2) (Fig. 1A). Cobalt cations appeared to be the most efficient
and were used in all MAP assays. In this study, our final goal
was to measure in vitro the values of catalytic cleavage of Met
cleavage (i.e. kcat/Km) and to compare these data with those
derived from N-terminal sequence analysis of proteins ex-
pressed in vivo. We therefore systematically measured the
kcat and Km values associated with a given peptide. Fig. 1B
provides an example of fit quality and shows the relevance of
fitting the Michaelis-Menten model to the data. With peptide
Met-Ala-Met-Lys-Ser, the substrate most efficiently pro-
cessed in this study, a catalytic efficiency value of 81,700 	
8,000 M1s1, associated with Km  0.05 	 0.01 mM and
kcat  3.9 	 0.2 s
1, was measured. These data, obtained for
more than 120 different peptides (compiled data are shown in
Supplemental Table S1), showed that both kcat and Km values
were extremely variable with ranges covering more than 2
orders of magnitude (0.01–4 s1 and 0.05–15 mM, respec-
tively). It would therefore not be possible to make reliable
comparisons between the data obtained for peptide concen-
trations of 4 and 20 mM in previous publications. These find-
ings also suggest that the enzyme worked below the kcat/Km
rate of cleavage as the steady-state peptide concentration is
about 0.1 mM.
In Vitro Characterization of E. coli Methionine Aminopepti-
dase: the S1 Site and the Influence of Peptide Length—We
assessed whether EcMAP1 could be used as a broader spec-
ificity aminopeptidase by varying the nature of the P1 side
chain (Fig. 2A). All experiments were carried out with tripep-
tides containing Ala and Ser in the second and third positions,
respectively. Met-Ala-Ser proved to be one of the most effi-
cient substrates in our analysis (see below and Supplemental
Table S1). We found that Met and its unnatural norleucine
Substrate Specificity of Methionine Aminopeptidase
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(Nle) classic mimic were the only residues at position P1 that
gave efficient cleavage. This finding is consistent with the
tapered shape of the S1 pocket (41). The natural amino acids
Leu and Phe could be processed in vitro but with a catalytic
efficiency more than 3 orders of magnitudes lower. Similar
results were obtained with methionine sulfoxide (Mox) or nor-
valine (Nva), which features an n-propyl side chain. Decreas-
ing the length of the side chain to -aminobutyrate (Aba), an
unusual amino acid with a two-carbon linear side chain mim-
icking Cys and Ser, or Ala led to resistance to enzyme cleav-
age. We concluded that EcMAP1 could not further process its
natural substrates and that the kinetic data were representa-
tive of a single cleavage site between P1 and P1 provided
that Met was the first amino acid of the peptide.
We investigated the role of the interface between the P1
and P1 sites by synthesizing three peptides derived from
Met-Ala-Ser: one with 2-methyl alanine (2mA), the second
with oxamic acid (no side chain but with a keto group instead,
Oxa), and the third with a D-Ala in position 2 replacing L-Ala.
The first two peptides were not cleaved. This was in contrast
to the D-Ala variant at P1 that was 2 times more efficiently
cleaved (Table S1). Thus, both geometry and the hydrogen
environment around the  carbon of the second residue had
a critical influence on cleavage by EcMAP1.
We also investigated the impact of the length of the
polypeptide chain. We first confirmed that EcMAP1 cleaved
dipeptides extremely inefficiently: Met-Ala or Met-Gly were
cleaved with a kcat/Km value 2 orders of magnitude lower than
that for the reference tripeptide with a serine in position P2
(Supplemental Table S1). In contrast, tripeptides and larger
peptides starting with Met-Gly proved to be efficient sub-
strates (Fig. 2B). We assessed the impact of side chain and
length by comparing two peptides series. The last amino acid
in these two series of peptides was Gly or Met, and the linker
peptide consisted of Gly. The kcat/Km value was found to be
maximal for peptides more than five residues long (Fig. 2B).
Comparison of the data obtained for peptides of a given
peptide length between the two series indicated that the
FIG. 1. Validation of the continuous enzymatic assay of MAP for
the medium throughput determination of catalytic efficiency. A,
influence of the metal cation on EcMAP cleavage efficiency. The
assay was performed in the presence of 0.2 mM of the indicated metal
cation, provided as a dichloride derivative in the solutions. The en-
zyme was also diluted in the presence of the concentration of the
metal salt. B, example of the determination of kinetic parameters and
fitting to a data set of the theoretical Michaelis-Menten equation. The
peptide used was Met-Ala-Met-Lys.
FIG. 2. Impact of P1 and peptide chain length on cleavage by
MAP. A, influence of P1 on MAP cleavage efficiency in vitro. The
peptide series was X-Ala-Ser where X is the indicated amino acid. A
value of 100 was assigned to the kcat/Km value of Met-Ala-Ser. B,
influence of peptide chain length. Two series of peptides were as-
sayed, Met-(Gly)n  2-Gly and Met-(Gly)n  2-Met where n  3–6 cor-
responds to the length of the peptide. Differences in length between
peptides were ensured by a poly-Gly linker. The x axis corresponds to
the full-length sequence. The shortest peptide tested was three amino
acids long. The kcat/Km value is plotted as a function of peptide chain
length. Mox, methionine sulfoxide; Nle, norleucine.
Substrate Specificity of Methionine Aminopeptidase
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nature of the side chain at position 3 (P2 site) or 4 (P3 site)
had a strong effect and that position 5 (P4 site) also had a
significant effect. A thorough analysis of the impact of the
amino acids at these positions is therefore required.
The S1 Subsite of EcMAP1: Difficult Cleavage of the Thr
and Val Residues—MAPs are known to cleave peptides se-
lectively between the terminal Met and the penultimate or P1
residue. In two tripeptide series, one with Ser and the other
with Gly at P2, we measured the catalytic efficiency of Met
cleavage for the complete set of amino acids with the excep-
tion of Cys (Fig. 3A). Ala was cleaved most efficiently followed
by Ser, Gly, and Pro. Thr and Val were cleaved less efficiently
with kcat/Km values 2 orders of magnitude lower in both series.
We could not determine kcat/Km values for other amino acids
(at least 5 orders of magnitude lower). In particular, peptides
with Ile, Asn, Asp, Met, or Leu at P1 were not cleaved. These
findings contrast with two reports using reporter proteins in
vivo (17, 18). At this stage, we do not know whether our in vitro
assay was representative of in vivo conditions or whether it
was not sensitive enough. Nevertheless there was a clear
relationship between gyration radius (as defined by Levitt (19))
of the side chain at P1 and catalytic efficiency as reported
previously (Fig. 3A). This relationship was fully confirmed in
the context of the most efficient series, the one derived from
tetrapeptide MXMK (with X  Ala, Gly, Pro, Ser, Thr, Val, Asn,
Ile, Leu, Asp, Glu, Phe, Gln, Lys, or Arg; data reported in
Supplemental Table S1). In contrast to previous reports sug-
gesting that Gly in the penultimate position gave the most
efficient processing, our data clearly show that the side chain
of Ala is optimal at P1. We analyzed two tripeptides with
unusual P1 side chains. One contained Nva, and the second
contained Aba, mimicking Cys and Ser, respectively. The
deduced kcat/Km values for these peptides were entirely con-
sistent with the model. This strongly suggests that the values
for Cys would be similar to that of Pro, which has the most
similar gyration radius (19).
In Vivo N-terminal Met Cleavage Is a Statistical Process
Mostly Dependent on the Catalytic Efficiency of MAP—The
data described above indicated that only peptides with Ala,
Gly, Ser, Cys, or Pro at P1 are substrates of EcMAP1 and that
the cleavage of peptides with Thr or Val at this position is less
predictable, possibly depending on other features. We com-
pared this in vitro analysis with in vivo results using compiled
data from N-terminal protein sequencing (data available at
ecogene.org/VerifiedInfo.php?downloadtrue). This analysisFIG. 3. Tight correlation between in vitro and in vivo cleavage
efficiency with variation of the penultimate (P1) residue. A, influ-
ence of P1 in vivo and correlation with side-chain radius gyration (19).
Two series were tested, Met-X-Gly and Met-X-Ser, where X is any
amino acid. Cys could not be tested directly (it is therefore shown in
italics here; see text); two unnatural amino acids, Aba and Nva, were
included. The catalytic efficiency (kcat/Km) is plotted as a function of
the side-chain radius gyration (data from Ref. 19). The nature of the
corresponding amino acid is given. “Others” corresponds to all nat-
ural amino acids not indicated in the figure. B, influence of P1 on in
vivo cleavage efficiency. Data were taken from the 862-sequence
database of proteins with determined N-terminal sequences. “Oth”
corresponds to all natural amino acids not indicated in the figure. C,
Met cleavage efficiency at P1 in vivo is directly correlated with MAP
cleavage efficiency assessed in vitro. The data set in Fig. 1 was
associated with that of A for a given amino acid at position P1. The
panel shows a plot of the cleavage efficiency in vivo for a given P1
position versus the activation energy (a value proportional to the
logarithm of the kcat/Km value; see Ref. 79) of the reaction in vitro
measured with a model substrate with the same P1.
Substrate Specificity of Methionine Aminopeptidase
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showed that 14.4% of the proteins are cleaved by a signal
peptidase. Cleavage usually occurs between two alanine res-
idues located at positions 23–27 of the polypeptide sequence.
The remaining proteins (85.6%) either retain or lose their
N-terminal Met. We analyzed this pool of proteins (738 se-
quences) to draw up the rules of NME in vivo and compared
the data obtained with our in vitro analysis. Cleavage was not
reported with Ile, Asp, Asn, Leu, Met, or Gln at P1. This fully
confirmed the results of our in vitro analysis, conflicting with
previous analyses based on reporter proteins (17, 18). No
cleavage was reported if the P1 residue was Arg, Phe, His,
Tyr, or Trp as suggested in vitro. Finally one cleavage with Glu
(42) and two with Lys (43, 44) at P1 were reported, but these
cleavages concerned only 3.0 and 1.5%, respectively, of all
the sequences containing these amino acids at this position.
These exceptional cases of cleavage may result from the
action of dedicated acylaminopeptidases rather than MAP as
shown previously for actin in animals (45, 46).
Met excision was not systematic with Ala, Cys, Pro, Ser,
Thr, and Val at P1 as 13% of such proteins escaped Met
cleavage (NME). Cleavage efficiency was maximal with Ala
(97%) and minimal with Thr (69%) and Val (64%) (Fig. 3B).
This efficiency was similar to that found in the kinetic analysis
shown in Fig. 3A. For each type of residue found at P1, we
therefore plotted in vivo cleavage efficiency as a function of
EcMAP1-mediated cleavage efficiency measured in vitro.
There was an extremely strong correlation between the two
data sets (Fig. 3C). Thus, NME or resistance to NME was
limited essentially by MAP catalytic efficiency in vivo, and the
data obtained in vitro were reliable for the modeling of NME in
vivo. We defined a “twilight cleavage zone” as the catalytic
cleavage efficiency leading to partial cleavage efficiency in
vivo (Fig. 3). Below this zone, cleavage is considered as
inefficient.
The S2 Subsite of EcMAP1: Pro and Glu Are Inefficiently
Cleaved Residues—We first investigated the impact of the P2
amino acid in the context of two series of tripeptides begin-
ning with Met-Ala, the most efficient substrate of EcMAP1,
and Met-Gly, an intermediate substrate for EcMAP1. The P2
side chain clearly had a strong effect on the catalytic effi-
ciency of Met excision catalyzed by EcMAP1. Some residues,
such as Pro and Glu, decreased the kcat/Km ratio by more than
an order of magnitude in both series with others, such as Asp,
Ile, and Thr, significantly decreasing this value by at least 1
FIG. 4. Comparison of the impact of
the nature of the P2 position on NME
in vitro and in vivo. A, influence of the
P2 position in vitro. The data came from
two data sets, one with Met-Ala-X (black
bars) and the second with Met-Gly-X
(gray bars), where X is any natural amino
acid. The relative catalytic efficiency
(kcat/Km) is plotted as a function of X. A
value of 100 was assigned to X  Ser in
both series. A black or gray asterisk (*)
indicates that the corresponding peptide
in either series was not characterized. B,
influence of the P2 position in vivo. Data
were taken from the 862-sequence da-
tabase of proteins with determined N-
terminal sequences. The efficiency of
Met cleavage was defined as the per-
centage of proteins with a M(A/C/G/P/
S/T/V) pattern resistant to Met cleavage
(385 instances). The general mean value
of 87% was used to display differences
optimally. Given the small number of in-
stances, an error bar corresponding to
one more or less uncleaved example
was introduced. Arrows indicate the
amino acids leading to significant de-
crease of cleavage efficiency in the
series.
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order of magnitude (Fig. 4A). Efficiency was optimal for pep-
tides with Trp, Met, or Ser at P2 as these residues increased
the kcat/Km ratio. Other residues gave intermediate values. We
next analyzed the impact of the P2 position on the efficiency
of cleavage in vivo using cleavage data for this position in the
385-sequence data library. The data are displayed in Fig. 4B.
They show a clear trend toward difficult cleavage when the
P2 residue is Asp, Glu, Ile, Pro, or Thr. Phe and Tyr were also
suggested to decrease cleavage efficiency in vivo, although
this prediction was not consistent with the data for catalysis.
Nevertheless the small number of peptides containing these
residues resulted in the data not being robust enough for
confident prediction of the in vivo behavior linked to the
presence of these two aromatic amino acids at position P2
(Fig. 4B). We concluded that the kinetic data were represent-
ative of the in vivo efficiency of cleavage.
In a second series of investigations of the impact of position
P2 in EcMAP1 cleavage, we assessed tripeptides with Thr or
Val at position P1, corresponding to substrates for fastidious
cleavage by EcMAP1 (i.e. zone leading to the twilight cleav-
age zone). A similar trend was observed for this series (Fig.
5A): Pro and Glu and, to a lesser extent, Asp and Thr at P2
were less likely to result in cleavage than other residues. If we
considered only those proteins starting with Val or Thr at P1,
the number of examples was significantly reduced, and the
statistics were therefore not robust enough for significant
conclusions to be drawn, but Glu and Pro seemed to reduce
cleavage efficiency (Fig. 5B). We concluded that the cleavage
of proteins with M(V/T)(E/P) patterns was virtually impossi-
ble in vivo and that the cleavage of proteins withM(V/T)(D/T)
patterns was difficult (i.e.“inefficient”), resulting in partial Met
retention in some cases.
The S3 Subsite of EcMAP1 Shows Negative Discrimination
Similar to That for the S2 Subsite—In a final systematic
search for EcMAP1 cleavage criteria, we investigated the role
of position P3 and P4. Data were obtained with a tetrapep-
tide, Met-Gly-Met-X, in which position X (P3) was varied with
all natural amino acids (except Cys). Significant differences
were observed, but only Asp, Glu, Pro, and Thr, i.e. the same
residues as for P2, resulted in a significantly lower cleavage
efficiency (Fig. 6A). Another set of data were obtained with a
pentapeptide, Met-Gly-Gly-Gly-X, in which position X (P4)
was varied with a reduced set of 10 amino acids (Fig. 6B). Phe
was the most efficient, and Glu (again) was the least efficient
residue. Cleavage efficiency was only modestly increased
when peptides Met-Ala-Met-Lys and Met-Ala-Met-Lys-Ser
were compared (Supplemental Table S1). The impact of P3
or P4 in vivo was investigated (Supplemental Fig. S1). Con-
cerning position P4, a negative influence of Cys and to a
lesser extent Glu and His emerged (Supplemental Fig. S1B).
The set of fastidious cleavage substrates with Val and Thr at
position P1 was next investigated. The very small size and
the composition of the sample analyzed with Val and Thr (only
91 cases covering 18 different residues) resulted in less con-
clusive data than for position P2 (Supplemental Fig. S1AB).
Nevertheless the negative impact of Cys, Glu, His, and Pro at
P4 appeared clearly (Supplemental Fig. S1C).
FIG. 5. Impact of the nature of P2 on
NME when P1 is a residue processed
inefficiently (i.e. Thr or Val) for MAP. A,
influence of the P2 position in vitro. The
data were obtained from two data sets,
one with Met-Val-X (black bars) and the
second with Met-Thr-X (gray bars),
where X is the indicated natural amino
acid. The relative catalytic efficiency
(kcat/Km) is plotted as a function of X. A
value of 100 was assigned to Met-Ala-
Ser. A black or gray asterisk (*) indicates
that the corresponding peptide in either
series was not characterized. B, influ-
ence of the P2 position in vivo. Data
were taken from the 862-sequence da-
tabase of proteins with determined N-
terminal sequences. The efficiency of
Met cleavage was defined as the per-
centage of proteins with a M(A/C/G/P/
S/T/V) pattern resistant to Met cleavage.
Arrows indicate the amino acids leading
to significant decrease of cleavage effi-
ciency in the series.
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Cleavage Specificity Is Very Similar for Type-1 and Type-2
MAPs—We extended our analysis to type-2 MAP, performing
the same analysis with P. furiosusMAP (PfMAP2), an archaeal
enzyme. Little is known about the cleavage capacity of Pf-
MAP2. Cleavage data are reported in the Takara catalog
(catalog number 7335), but no detailed protocol is described.
We extended our study aiming to confirm the validity of our
peptide array by studying PfMAP2-mediated cleavage in de-
tail. This enzyme was characterized under the same condi-
tions as EcMAP1. A catalytic efficiency of 44,275 	 10,000
M1s1, associated with Km  0.9 	 0.2 mM and kcat  38 	
3 s1, was measured for this enzyme with Met-Gly-Met-Met,
the most efficiently processed substrate studied. This cata-
lytic efficiency is similar to that reported for EcMAP1 (see
above).
We then studied a set of substrates with various residues in
the P1 and P2 positions (the complete data are reported in
Supplemental Table S2 and displayed in Fig. 7). For P1, the
data obtained were similar to those obtained with EcMAP1
(Fig. 7A) and those available from Takara with peptide series
MXAAA (where X is any natural amino acid except Cys). Thus,
although MAP1 and MAP2 differ in terms of their amino acid
sequences, the S1 binding pockets of these two types of
enzyme have similar sieve capacities. Cleavage was optimal
for Ala and Pro and minimal for Thr and Val. The enzyme
showed a strong preference for large hydrophobic side
chains, such as those of Met and Trp, in the P2 position with
strong hindrance observed for residues such as Glu and Pro
and, to a lesser extent, Thr, Ile, and Asp (Fig. 7B). Some
differences were observed between MAP1 and MAP2. For
example, Ser and, to a lesser extent, Lys in P2 were less
optimal for MAP2 cleavage than for MAP1 cleavage, but the
presence of these residues is unlikely to have a major effect
on cleavage efficiency.
Thus, the substrate specificities of PfMAP2 and EcMAP1
seem to be similar, including for instance difficult cleavage if
Thr or Val is at P1 and if Glu or Pro is at P2. This similarity
was unexpected given the differences in the sequences of the
two enzymes. To give access to these data for the whole
community, we created a prediction tool, TermiNator2. This
predictor was created as a web tool by combining php/HTML/
MySQL/javascript languages to predict NME in prokaryotes
(i.e. both eubacteria and Archaea) and other associated N-
terminal modifications in eukaryotes. It is available on line at
www.isv.cnrs-gif.fr/terminator2/index.html. This tool allows
also complete proteomes to be analyzed (see below).
The Predicted N-terminal Proteome Shows a Strong Bias
toward MAP Substrates with Respect to the Proteome De-
duced from the Most Abundant Proteins—The E. coli data
sets studied included both in vivo and in vitro studies, making
FIG. 6. Comparison of the influence
of the nature of the P3 and P4 posi-
tions on Met cleavage in vitro. A, influ-
ence of the P3 position in vitro. The data
were obtained with the Met-Gly-Met-X
peptide where X is any natural amino
acid. The relative catalytic efficiency
(kcat/Km) is plotted as a function of X. A
value of 100 was assigned to X Gly. B,
influence of the P4 position in vitro. The
data were obtained with the Met-Gly-
Gly-Gly-X peptide where X is any natural
amino acid. The relative catalytic effi-
ciency (kcat/Km) is plotted as a function
of X. A value of 100 was assigned to X 
Ser. Arrows indicate the amino acids
leading to significant decrease of cleav-
age efficiency in the series.
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this a unique system for further functional analysis of the
impact of the N-terminal residue. In a previous analysis of the
E. coli NME machinery, we showed that MAP was the primary
determinant of the nature of the N terminus of a protein and
that the most sensitive position for EcMAP1 action was po-
sition P1 (Fig. 3). We investigated the frequency and nature of
particular N-terminal residues in E. coli. We extracted all pro-
teins with the same penultimate (P1) residue from the com-
plete proteome of E. coli (4071 entries) and calculated the
percentage of proteins with each of the amino acids in the
penultimate position. We compared this data set with that
calculated only for proteins with N-terminal sequences that
had been determined and shown to follow the rules of NME
(738 entries; Fig. 8A). All residues predicted to undergo NME,
except Val, the least efficiently processed of these substrates,
were underrepresented by a factor of 2–3 in the complete
proteome with respect to the restricted proteome. These data
suggest that the accumulation of proteins sensitive to NME is
favored in bacteria. Using the MAP cleavage prediction tool,
TermiNator2, and the complete proteomes of E. coli (repre-
sentative of Gram-negative bacteria), B. subtilis (representa-
tive of Gram-positive bacteria), and P. furiosus (representative
of Archaea), we predicted the N-terminal amino acid distribu-
tion. In each of these cell types, the N-terminal amino acid
distribution was very similar, featuring Met as the major N-
terminal residue (Fig. 8B). Residues appearing as a result of
NME corresponded to less than 30% of the proteome. These
data indicate that (i) E. coli is a good model for NME studies in
prokaryotes and that (ii) NME involves only a minority of the
proteins in a given proteome in contrast to the general belief.
In addition, we investigated whether these findings were
biased by the lack of consideration of leader peptide removal
(LPR). LPR may play an important role, in addition to MAP
cleavage, in influencing the exposure of specific and function-
ally important N-terminal residues. Another possible bias is
the dependence of NME on the residue in the P1 position and
also on the residues in the P2 and P3 positions (Fig. 3B).
Therefore, a second series of predictive analyses were per-
formed based on the 4071 entries of the compete proteome of
E. coli, taking into account both (i) the extent of LPR and (ii)
Met cleavage efficiency (data shown in Fig. 3B). Statistical
analysis of the restricted proteome (862 entries) was used (i)
to predict the extent of LPR (14.4%) in a robust manner and (ii)
to determine the nature and probability of the appearance of
a new N-terminal amino acid as a result of LPR (i.e. Ala 
Asp, Glu, Lys  Val  Gln, His, Tyr; values indicated in the
legend to Fig. 8). Our data are consistent with published
results (47), which reveal a clear bias in cleavage site selection
and in the nature of the amino acid unmasked at the N
terminus. We used these data and the associated probabili-
ties to calculate the mean percentage of mature proteins from
the complete proteome with a given amino acid at their N
terminus (Fig. 8C, black bars). As many as 60% of the proteins
considered were predicted to retain their N-terminal Met res-
idue. These data were compared with experimental data ob-
tained by Edman N-terminal sequence determination of crude
E. coli extracts (white bars; average of data from Refs. 8–10
and 23). The experimental data set differs from the calculated
data in that only 35 	 5% of the proteins were found to retain
their N-terminal Met residue. This value is half that obtained
theoretically. In contrast, both Ala and Ser appeared to be
overrepresented as N-terminal residues in the experimental
data sets. These data indicate that taking into account LPR is
not sufficient for significant modification of the data shown in
Fig. 8, A and B, and that there is indeed (i) a strong bias
FIG. 7. Impact of P1 and P2 positions on MAP2 cleavage effi-
ciency in vitro. A, influence of P1 in vivo and correlation with
side-chain radius gyration (19). Two series were tested, Met-X-Gly
and Met-X-Ser, where X is any amino acid. “Oth” corresponds to all
natural amino acids not indicated in the figure. B, influence of the P2
position in vitro (black bars) and comparison with EcMAP (white bars).
The data were obtained from the Met-Gly-X series where X is any
natural amino acid. The relative catalytic efficiency (kcat/Km) is plotted
as a function of X. A value of 100 was assigned to X  Met in both
series. Arrows indicate the amino acids leading to significant de-
crease of cleavage efficiency in the series.
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toward the in vivo accumulation of proteins losing their N-
terminal Met and/or (ii) a negative bias against proteins resist-
ant to NME.
DISCUSSION
We report here the first extensive, coherent, and compre-
hensive analysis of the substrate specificity of MAP in vitro.
Our data indicate that the P1, P2, and P3 positions of the
protein substrate (i.e. the three residues following the first Met
(P1 position)) have a major effect on cleavage efficiency. Our
data were obtained with MAPs of both types: type-1, exem-
plified by E. coli MAP, and type-2, exemplified by P. furiosus
MAP. The E. coli system, with a large number of available
protein sequences, has provided unique information, making
it possible to demonstrate a direct correlation between MAP
activity in vitro and NME in vivo. Together these data indicate
that the assessment of MAP catalytic efficiency in vitro is the
best way to assess MAP cleavage efficiency in vivo. Based on
our data, we also developed a new bioinformatics tool for
improving Met cleavage prediction for prokaryotic, eubacte-
rial and archaeal, MAPs that is available from www.isv.cnrs-
gif.fr/terminator2/index.html. The prediction of Met cleavage
for organellar and nucleus-encoded eukaryotic proteins is
also possible via the same site using data for the prokaryotic
enzyme (this work and Ref. 48).
NME Prediction of Natural Bacterial Substrates and Recom-
binant Proteins Overproduced in E. coli—The nature of posi-
tion P1 in a polypeptide chain affects cleavage efficiency,
depending on the nature of the amino acid, from highly effi-
cient cleavage, as observed with Ala, to fastidious cleavage,
as seen with Thr and Val. MAP kcat/Km (catalytic efficiency)
and in vivo cleavage efficiency were found to be directly
correlated (Fig. 3C). This explains why most proteins resistant
to NME according to the usual rules of thumb have Val or Thr
in the penultimate residue. Positions P2 and, to a lesser
extent, P3 and P4 also affected cleavage probability with the
same series of amino acids, Asp, Glu, Pro, and Thr, having a
negative effect. A Glu or a Pro at P2 appeared to have the
most negative effect. For the prediction of MAP cleavage in
vivo directly from analysis of the N terminus of a protein, it is
important to take into account whether the protein is (i) a
natural protein substrate or (ii) an overproduced recombinant
protein. For natural substrates, we suggest that proteins be-
ginning with a M(^ACGPSTV) or M(V/T)(E/P) (note that
“(^XY)” means that residues X and Y or a subset list is ex-
FIG. 8. Existence of a strong positive bias between proteins
with an N terminus identical to that revealed by NME and proteins
accumulating in vivo. A, comparison between the penultimate (P1)
residues predicted in the 4071 ORFs annotated in the E. coli genome
(black bars) and those of the 862-protein set for which the N-terminal
residue has been determined by sequencing (white bars). The pro-
teins undergoing LPR (14.4%) in this second set were excluded from
the analysis. B, amino acids unmasked by NME in various prokaryotic
proteomes. The TermiNator2 prediction tool was used to analyze the
three complete proteomes from E. coli, B. subtilis, and P. furiosus.
LPR was not considered and assumed to be 0 (see C). C, comparison
of a model of N-terminal protein maturation in vivo, predicting the
nature of the N-terminal residue (calculation involved the 4071 ORFs;
black bars), with the average of N termini (white bars) determined from
two-dimensional gel electrophoresis (data from Ref. 23) and crude
extracts (data from Refs. 8–10). The bioinformatic model took into
account the efficiency of NME in vivo as a function of the nature of the
residue in the P1 position, as shown in Fig. 3B, and the LPR of 14.4%
of the proteins. In this subset (data available from Ref. 23), we as-
sumed that 57% of the proteins undergoing LPR eventually start with
Ala, 12.2% with Asp, 10.2% with Glu, 8.2% with Lys, 4.1% with Val,
and 2% with each of Gln, His, Phe, and Tyr, respectively. “Oth”
corresponds to the sum of all the other amino acids (0.1%). This
assessment was highly consistent with the data set shown in Fig. 1
(for Gram-negative bacteria) of Ref. 47. Data were calculated from the
same set but with a probability of LPR of 29% (gray bars, tendency up
to 42% is schematized with a black arrow on the bar) rather than
14.4% (black bars).
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cluded, and “(Y/Z)” means that residue Y or Z or a subset list
is included; X, Y, or Z correspond to any normal amino acid)
are unlikely to be cleaved. There is a strong risk of lack of
cleavage for proteins beginning with M(G/P/V/T)(D/T)(D/E/
P/T), M(G/P/V/T)(D/T)(^DEPT)(C/E/H/P), and M(G/P/V/T)-
(^DEPT)(D/E/P/T)(C/E/H/P). In this last situation, incomplete
maturation in vivo is most likely to occur, resulting in two types
of the protein: one, major with an N-terminal Met, and the
other, minor without an N-terminal Met. There are already a
few well documented examples of such behavior (23). These
simple rules account for 60% of the proteins displaying as yet
unexplained Met retention in the proteome of E. coli.
E. coli is widely used for the overproduction of recombinant
proteins. In the last 20 years, many instances of improperly
processed N termini have been reported. This recurrent issue,
known as the “methionine problem” (49), has not yet been
resolved. MAP cleavage is thought to become limiting be-
cause the amount of overproduced protein exceeds the ca-
pacity for MAP activity. Our findings are entirely consistent
with MAP activity being the limiting factor for NME in vivo (Fig.
3C). They also suggest that the conclusions drawn from stud-
ies based on overproduced reporter proteins (17, 18) should
be interpreted with caution. Unexpected complete or partial
Met retention is known to lead to many defects, including an
increase in antigenicity or a decrease in biological activity.
This is true for the N-terminal nucleophile hydrolase (Ntn)
family of enzymes, which use both the free N terminus and the
corresponding Thr, Ser, and Cys side chains in the catalytic
mechanism (50) as reviewed in Ref. 51. Before envisaging the
production of a protein in E. coli, particularly for heterologous
proteins, the NME behavior of the protein must be correctly
predicted to ensure that the expected protein, with the ex-
pected N terminus, is produced. The data reported herein is
particularly useful in this respect as illustrated by the following
examples concerning the production of human proteins of
therapeutic interest by recombinant DNA methods in E. coli.
“Unexpected” blockage of Met cleavage has been reported
for granulocyte colony-stimulating factor (Met-Thr-Pro-Leu;
see Ref. 52) and - or -hemoglobins (Met-Val-His-Leu; see
Ref. 53). In all these cases, the overproduced protein contains
a fastidious P1 (Val or Thr) residue as revealed in our study
(Fig. 3), and one of these proteins also contains the most
negative P2 residue, Pro. Other well documented examples
of Met retention include the cytokine RANTES (regulated on
activation normal T cell expressed and secreted) (Met-Ser-
Pro-Tyr) and the interleukins 1 and 2 (Met-Ala-Pro-Thr/Val;
see Refs. 54 and 55). For the interleukins, Met cleavage is
crucial as the N-terminal Ala must interact with the C-terminal
Thr-133 (56). Our study provides a rationale for the retention
of Met as both Pro and Thr at positions P2 and P3 tend to
inhibit Met cleavage. Another example is provided by inter-
leukin-6, which begins with Met-Pro-Val-Pro (57). We show
here that a Pro at position P3 significantly decreases the
efficiency of the process. We conclude from the aforemen-
tioned examples that, when a given protein is overproduced,
substrates displaying fastidious cleavage by MAP may not be
completely processed by this enzyme. The prediction of MAP
cleavage must therefore be more stringent than for intrinsic
proteins. We suggest that processing is highly unlikely to
occur for overproduced proteins beginning with M(A/G/P/
S/T)(D/E/P/T)(D/E/P/T), M(A/G/P/S/T)(^DEPT)X(C/E/H/P),
M(A/G/P/S/T)X(^DEPT)(C/E/H/P), or MV(D/T) and that
there is a risk of non-processing for proteins beginning with
M(A/G/P/S/T)(D/E/P/T) or MV(^DEPT), leading to partial
Met retention. This rule should be useful for predicting the
likelihood of cleavage for recombinant proteins. To this aim,
we therefore added an option relative to the overexpression of
any favorite protein in the TermiNator2 prediction tool. If the
protein has an N terminus associated with a risk of non-
processing, various methods may be used to prevent Met
retention: (i) adjusting expression conditions to optimize MAP
activity according to the rate of protein synthesis in vivo (58),
(ii) in vitro processing with purified wild-type or engineered
MAP (59–62), (iii) dual co-overproduction of MAP and the
protein of interest in vivo (25, 63, 64), (iv) processing in vitro or
in vivo of the N terminus with another amino- or endoprotease
(65–67), or (v) fusion of the ORF to a propeptide or ubiquitin
sequence and use of endogenous signal peptidase specificity
(68, 69). This last strategy has also proved successful for
residues that cannot be unmasked by NME (this study, Fig. 3),
such as the thrombin inhibitor hirudin, which must have Ile at
its N terminus for biological activity, or human growth hor-
mone, which must have Phe at its N terminus (70–73).
Comparison of NME Rules between Eubacteria and Ar-
chaea—In Archaea, most mature proteins have Ala, Met, Gly,
Ser, Thr, or Pro at their N terminus (10). The N-terminal Met of
proteins is believed to be frequently cleaved by MAP2 in
Archaea, although few data are available to confirm this. This
assumption is consistent with the in vitro data presented here
(Fig. 7A). Specifically we have demonstrated that the rules gov-
erning cleavage are similar for MAP2 and MAP1, involving not
only the P1 site but also the true P2 and P3 sites (Fig. 7B).
Archaea display 8–9% signal peptide cleavage, a fre-
quency significantly lower than that in eubacteria (15–37%;
Ref. 74). NME is therefore of greater importance for exposing
the N termini of most proteins. The consequences of the
observed differences in MAP substrate specificity for Met
cleavage in vivo should be taken into account. In Archaea, the
rules governing NME do not differ significantly from those of
eubacteria with similar trends observed at P1 and P2. We
conclude that the use of identical cleavage rules should make
it possible to predict NME accurately in Archaea.
Physiological Relevance of Improved NME Prediction for
the E. coli Proteome—By improving NME prediction for nat-
ural proteins of the bacterial proteome, we were able to model
the effect of this process on the whole proteome (Fig. 8). We
observed an overrepresentation of proteins undergoing NME
in bacteria: those that resisted the process and had se-
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quences starting with a Met were underrepresented (Fig. 8C).
We tried to account for this discrepancy by modeling the
impact of inadequate LPR assessment. The frequency of LPR
used (14.4%) was directly deduced from data obtained from
the 862-protein database. Interestingly this value is identical
to that obtained from bioinformatics analysis using a maximal
stringency cutoff applied to the complete proteome of Hae-
mophilus influenzae (14% in Ref. 47). H. influenzae is a Gram-
negative bacterium closely related to E. coli but with a signif-
icantly lower (by a factor of 2.5) number of associated ORFs
(75). Doolittle (75) estimated that the signal peptide cleavage
frequency might reach 15–20%, which is slightly higher than
the frequency used here. A maximal value of 28% was pro-
posed with lower stringency scoring. This value is consistent
with other predictions of 25% in H. influenzae and 29% in
E. coli (74). A higher frequency of signal peptide cleavage
might therefore account for the bias observed in the distribu-
tion of N-terminal amino acids. It should be borne in mind that
the proteins analyzed correspond to a class of proteins with a
compartmentation bias as these proteins are (i) soluble (as
opposed to membrane proteins) and (ii) not secreted outside
the bacterium as the only secreted proteins that can be re-
trieved by the fractionation strategies used are those exported
to the periplasmic space. LPR is thought to be frequent in
membrane and secreted proteins. We therefore modeled the
impact of increasing LPR frequency. Only a huge increase in
the proportion of these proteins to 42% (3 times experimental
values) gave a satisfactory fit of N-terminal Met frequencies to
the experimental values (Fig. 8C, end of arrows in gray bars).
However, the correlation with Ala, Ser, and Thr was very weak
with this value. Finally this value of 42% is much higher than
the upper value of 29% proposed previously (74). A value of
29% gave a much better fit to the data (Fig. 8C, gray bars). We
conclude that the protein pool undergoing signal peptide
cleavage is probably underestimated in our study but that this
underestimation alone is unlikely to account for the trend
observed toward a lower content of proteins retaining their
N-terminal Met.
Most of the data for the 862-sequence compilation con-
cerned proteins extracted by two-dimensional gel electro-
phoresis (23). As a result of this, these proteins were probably
the most abundant proteins in the bacterium. Another possi-
ble reason for the poor correlation between the data sets in
Fig. 8C is likely due to the assumption that the genes for these
abundant proteins may have been selected to encode resi-
dues such as Ala or Ser at P1 so that their N-terminal Met is
efficiently cleaved and recycled. Met is indeed an “expensive”
amino acid to biosynthesize. The capacity to recover a ma-
jority of the N-terminal Met (i.e. especially those correspond-
ing to the most abundant proteins) could have been favored
throughout bacterial evolution (see also concluding remarks in
Ref. 21 for further discussion). One could also suggest that all
or some of the proteins retaining their N-terminal Met are likely
to be less stable. Recent data obtained in the search for
proteins cleaved by the ClpAXP proteolytic machinery of
E. coli have indeed identified an N-terminal motif including an
N-terminal Met. The recurring N-terminal motif MK

X

(where 
 is any hydrophobic amino acid and X is any amino
acid) is involved in cleavage by the bacterial ClpAXP protease
(76). This hypothesis seems likely given that Lys is the most
frequent amino acid in position 2 (Fig. 8A) and prevents NME.
However, a less stringent motif would be required to obtain a
better fit to the experimental values. It should be noted that a
single proteolytic cleavage of a mature protein by cellular
machinery other than a leader peptidase and ClpAXP may
lead to enhanced protein degradation. This hypothesis, in
which protein half-life and signal peptide prediction accounts
for the amino acid bias observed in experimentally deter-
mined protein N termini with respect to proteomic predictions,
may also account for the accumulation of fewer proteins with
an N-Met than predicted on the basis of the genome se-
quence (Fig. 8B).
Generalization, Introducing a Bioinformatics Tool to Predict
NME—We show here that detailed characterization of the
catalytic efficiency of MAP can be used to predict the in vivo
Met cleavage of any protein of a given proteome. NME pre-
diction within the proteome is indeed crucial as a database of
protein N termini as representative (i.e. about 20%) as that
available for E. coli will probably never be available for any
other organism. However, published data for the two cytosolic
Saccharomyces cerevisiae MAPs (ScMAPs) suggest that the
substrate specificity of these enzymes may differ from that of
prokaryotic MAPs. For example, studies of ScMAP1 have
shown fastidious processing of peptides with Pro at P1 or
with Val or Thr in this position (Fig. 4A in Ref. 40). Studies with
ScMAP2 and low concentrations of peptide (i.e. mimicking
kcat/Km conditions) have suggested fastidious processing for
peptides with Pro at P1 but not with Val in this position (Table
V in Ref. 77). Thus, in higher eukaryotes, prediction is com-
plicated by the occurrence of at least one MAP1 and one
MAP2, which do not necessarily have identical specificities. If
the two enzymes have similar specific activities in vivo, cleav-
age efficiency is likely to be increased. However, this does not
appear to be the case in yeast in which MAP1 behaves as the
most active, major MAP (78). Data on relative MAP expression
and regulation are therefore required to complement predic-
tion algorithms.
The associated crucial physiological consequences, such
as protein stabilization associated with Met removal, highlight
the importance of correctly predicting the N termini of pro-
teins as recently reported for higher eukaryotes (48). Further
detailed kinetic characterization of the actual substrate spec-
ificity of each eukaryotic MAP is required to increase the
confidence of predictions made with this tool.
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